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Preparations of plasmid containing the thymidine kinase gene (pHSV106) were treated with the alkylating 
agents methyl methanesulphonate or N-methyl-N-nitrosourea prior to transfection into thymidine kinase- 
deficient mouse L-cells using the DNA-calcium phosphate co-precipitation technique. Relative to transfec- 
tion with unmodified plasmid, a reduced transformation efficiency was observed using alkylation-damaged 
plasmid, N-methyl-N-nitrosourea causing the greatest inhibition. Treatment of recipient cells with arabino- 
syl cytosine or dideoxythymidine during the expression period following transfection by the ‘damaged’ plas- 
mid reduced transformation efficiency, suggesting that DNA repair 4-6 h post-transfection was required 
for gene expression. 
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1. INTRODUCTION 
Foreign genes may be integrated stably into 
mammalian cells and expressed for several genera- 
tions using calcium phosphate-DNA-mediated 
gene transfer [l]. This technique has been used by 
several groups to examine the effects of carcinogen 
damage to the transfecting gene and its repair by 
recipient cells [2-41. Reports of the transforming 
efficiencies of damaged plasmids differ, however, 
with ultraviolet radiation causing a dose- 
dependent increase in transformants [2] and reac- 
tion with benzo[a]pyrene diol-epoxide effectively 
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reducing the transforming ability of plasmid 
preparations [3]. That transfected cells are capable 
of repairing plasmid lesions introduced in vitro has 
been demonstrated following both ultraviolet 
damage [4] and double-stranded breaks caused by 
restriction endonucleases [5,6]. We have sought to 
describe the effect of the alkylating agents MMS 
and MNU on the biological activity of a recombi- 
nant plasmid containing the viral thymidine kinase 
gene (pHSV106), following transfection into TK- 
deficient mouse L-cells. In order to assess the 
potential of transfection-based assays to 
characterize DNA damage and repair preliminary 
examination has been made of the effect of in- 
hibitors of DNA polymerases at various stages 
throughout the expression period. 
2. MATERIALS AND METHODS 
For plasmid modification, “C-labelled MMS or 
MNU (Amersham, Bucks, England) in DMSO 
solution at the indicated concentrations were 
reacted with 2 pg of plasmid pHSV106 DNA [7,8] 
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(generous gift of Dr M. Sleigh, CSIRO, North 
Ryde, NSW) in 10 mM Tris-HCl/l mM EDTA 
(TE buffer, pH 7.5) or citrate buffer (pH 6.0) 
respectively prior to ethanol precipitation of the 
DNA and redissolving in TE buffer (200~1). The 
percentage modification by MMS and MNU was 
determined by calculating the molar ratio of DNA 
to chemical using A269nm values and the specific ac- 
tivity of the labelled compound. 
Mouse LTK-/aprt- cells [9], maintained as 
monolayers in Dulbecco’s modified Eagle’s 
medium (Gibco) with 10% calf serum and an- 
tibiotics, were routinely passaged 1:3 once per 
week. 4 x lo5 mouse LTK- cells were seeded 24 h 
before transformation and transfections were car- 
ried out using the calcium phosphate-DNA co- 
precipitation technique [ 11. Briefly, cells were ex- 
posed to the precipitate for 24 h, and following 
removal of the transfecting DNA, were allowed 
24 h in fresh medium before selection. TK+ col- 
onies were then selected in HAT medium and were 
fixed, stained and counted 14 days following 
transfection. For studies involving inhibitors, 
medium was removed from the cells for 2 h 
periods during the 24 h post-transfection interval 
and, where appropriate, replaced with fresh 
medium or medium containing ara-C (20pM) or 
ddT (1 mM). After the 2 h pulse period, fresh 
medium was provided for the remainder of the 
24 h growth period. Cells were then selected in the 
usual manner. 
3. RESULTS 
The effect of alkylation on the biological activity 
of the TK gene was assessed by determining the 
transformation efficiency. Upon selection of stable 
transformants using HAT medium, numbers of 
colonies were invariably reduced after transfection 
with modified DNAs compared to untreated 
plasmid (table 1). Transfection with either MMS- 
or MNU-damaged plasmid yielded a consistent 
relationship between increasing levels of modifica- 
tion and inactivation of the gene. Loss of gene ex- 
pression occurred at much lower levels of 
modification with MNU than with MMS. 
The effects of ara-C and ddT on the expression 
of the exogenously added TK gene were deter- 
mined by addition of the inhibitors to the medium 
for 2 h periods throughout the 24 h following ex- 
Table 1 
Effects of modification on expression of the TK gene 
following transfer to LTK- cells 
Carcinogen/ 
DNA 
Concen- % modi- TK+ clones/ 
tration fication 10 ng DNA 
(u&r//G) 
- /pHSVlOB - - 204.0 f 19.1 
MMS/pHSV106 1 33 75.1 f 8.5 
0.1 11 91.4 f 4.3 
0.01 0.3 167.7 + 18.9 
0.001 - 143.0 f 19.3 
MNU/pHSV106 1 6.3 11.7 f 2.0 
0.1 1.2 55.9 f 15.4 
0.01 0.12 88.9 + 20.5 
0.001 - 121.8 + 9.9 
Plasmid pHSV106 was incubated with various 
concentrations of MMS or MNU. A 10 or 25 ng aliquot 
of modified DNA was used for transfection, which was 
performed as described in section 2. 48 h total 
expression time was allowed before selection in HAT 
medium. TK+ colonies were scored 14 days after 
transfection. The numbers of TK+ colonies indicate the 
mean f SD of several experiments 
posure to the DNA-calcium phosphate co- 
precipitate. Addition of either ara-C or ddT to the 
medium decreased transformation efficiency when 
the inhibitors were present immediately following 
transfection, ara-C reducing the yield to 22% of 
control value and ddT to 65% (table 2). Addition 
of ara-C at other times also reduced thymidine 
kinase expression, the most marked effect occur- 
ring when the compound was present 22-24 h 
post-transfection. In contrast, ddT did not reduce 
transformation efficiency when present 4-6 h and 
22-24 h after deposition of DNA. Addition of 
ara-C or ddT during the O-2 h or 22-24 h periods 
following transfection with alkylated DNA yielded 
similar results to those obtained with undamaged 
plasmid. However, addition of the inhibitors dur- 
ing the 4-6 h period markedly decreased the 
transformation efficiency observed with DNA 
damaged by MNU (table 3). The presence of ara-C 
during this period decreased, by a further 50070, the 
transformation efficiency observed with undam- 
aged plasmid. More significantly, ddT, which 
caused no decrease in transformation efficiency at 
this pulse time following transfection of undamag- 
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Table 2 
Effects of DNA replication/repair inhibitors on the expression of the TK 
gene 
DNA Time of Additions TK+ clones/ % control* 
medium change 10 ng DNA 
(h) 
pHSV106 24 162 f 3.6 100 
pHSV106 o- 2 ara-C 40 f 3.2 22 
4- 6 ara-C 77 f 13.5 43 
22-24 ara-C 10 f 2.0 8 
pHSV106 o- 2 ddT 119 f 25.6 65 
4- 6 ddT 220 f 26.0 122 
22-24 ddT 132 f 7.5 97 
a The percentage control values were obtained by comparison with the 
transformation efficiencies obtained in experiments in which only the 
medium was changed for the stated 2-h periods 
Cells were exposed to 20 PM ara-C or 1 mM ddT in fresh medium for 2-h 
periods within the 24 h following removal of the DNA-calcium 
phosphate co-precipitate 
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Table 3 
Effects of inhibitors on the transformation efficiency of 
DNA damaged by MNU 
DNA Time of Additions % control 
medium change trans- 
(h) formation 
efficiencya 
- /pHSV106 4-6 ara-C 43 
4-6 ddT 122 
MNWpHSV106 4-6 ara-C 20 
4-6 ddT 58 
a % control transformation efficiency is expressed by 
comparison with identical transfection plates in which 
only the medium is changed during the stated periods 
Experiments were performed as described in table 2 
except that DNA modified by reaction with MNU 
(1 pg/pg DNA) was used for the transfection 
ed plasmid, decreased the transformation efficien- 
cy by 50% when damaged plasmid was 
transfected. 
4. DISCUSSION 
Although expression of pHSV106 in mouse 
LTK- cells was decreased following damage to the 
plasmid by alkylating agents, transformation effi- 
ciency subsequent to damage was sufficiently high 
to allow further reduction by manipulation of 
cellular DNA repair processes. In analogous ex- 
periments, dose-response relationships between 
carcinogen-induced amage to DNA and variation 
in transformation efficiency have been described 
[2,3]. These, and the present observations have 
been made despite indications [lo] that the 
transfection process per se results in DNA damage. 
The effect of such ‘background’ damage on repair 
processes of recipient cells has yet to be clarified. 
In terms of gene inactivation MNU caused a 
greater effect at lower levels of modification than 
MMS, suggesting either that removal of MNU 
damage is less efficient or that generation of a 
critical lesion occurs more frequently with MNU. 
Reduction of the transformation efficiency 
(table 2) by addition of either ara-C or ddT to the 
medium immediately following removal of un- 
damaged transfecting DNA suggested a possible 
toxic effect of inhibitors on cells recovering from 
the transfection procedure. The decrease in 
transformation efficiency observed when ara-C is 
present 22-24 h post-transfection, implying that 
such inhibition of DNA polymerase c~ prevents ex- 
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pression, is consistent with relatively late replica- 
tion of the cellular DNA with incorporated viral 
TK gene [l,ll]. 
Evidence for the role of DNA repair in transfec- 
tion has been previously obtained using repair- 
deficient xeroderma pigmentosum cells as re- 
cipients in transfection assays with transient ex- 
pression of psVZcat as an end point [12,13]. In 
both cases, reduced expression of ultraviolet- 
damaged plasmid was observed in xeroderma 
pigmentosum cells compared to normal recipients. 
In our studies, transformation efficiency was 
markedly decreased by addition of repair in- 
hibitors during the 4-6 h post-transfection period 
when the plasmid was damaged with MNU (table 
3). The effect of ddT is conspicuous because, with 
intact plasmid, this agent did not reduce the 
number of colonies. The susceptibility of expres- 
sion to inhibitors of DNA polymerases a and /3 
[14] suggests that repair processes requiring both 
enzymes are involved during this period. Similar 
inferences regarding rapid repair arise from the 
observations of Mooibroek et al. [4] who examined 
transfection of ultraviolet-damaged DNA into 
fibroblasts and demonstrated no repairable 
damage persisting in the plasmid DNA 2-3 h 
following transfection. Our observations suggest 
that modification of the processes of DNA replica- 
tion and repair throughout the expression period 
following plasmid transfection can yield useful in- 
formation on factors influencing the expression of 
exogenous DNA in mammalian cells. 
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